Related Experiment Videos
Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects
P R Lyons1, P K Newman, M Saunders
1Department of Neurology, Middlesbrough General Hospital, Cleveland, UK.
Journal of Neurology, Neurosurgery, and Psychiatry
|February 1, 1988
Abstract:
A retrospective analysis of 350 treatment courses using high dose pulsed intravenous methylprednisolone for relapses of multiple sclerosis revealed a low number of adverse effects. This study confirms that high dose methylprednisolone is a safe therapeutic option in multiple sclerosis.